{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:47:20Z","timestamp":1791978440943,"version":"4.4.0"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA055703"],"award-info":[{"award-number":["R01 DA055703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH093320"],"award-info":[{"award-number":["R01 MH093320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH106978"],"award-info":[{"award-number":["R01 MH106978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DA046044"],"award-info":[{"award-number":["R21 DA046044"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DA049044"],"award-info":[{"award-number":["R21 DA049044"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U18 DA052527"],"award-info":[{"award-number":["U18 DA052527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.pharmthera.2023.108574","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T17:55:51Z","timestamp":1702144551000},"page":"108574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Organic cation transporters in psychiatric and substance use disorders"],"prefix":"10.1016","volume":"253","author":[{"given":"Lauren E.","family":"Honan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheaclare","family":"Fraser-Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette C.","family":"Daws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108574_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.32","article-title":"Overview of monoamine transporters","volume":"79","author":"Aggarwal","year":"2017","journal-title":"Current Protocols in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0010","first-page":"199","article-title":"Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: Pivotal role of pre- and post-synaptic 5-HT1A receptor expression","volume":"9","author":"Albert","year":"2014","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/dmd.105.006932","article-title":"Tissue distribution and ontogeny of organic cation transporters in mice","volume":"34","author":"Alnouti","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108574_bb0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","article-title":"Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain","volume":"50","author":"Amphoux","year":"2006","journal-title":"Neuropharmacol"},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108574_bb0025","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.3390\/ijms222312995","article-title":"Interaction profiles of central nervous system active drugs at human organic cation transporters 1-3 and human plasma membrane monoamine transporter","volume":"22","author":"Angenoorth","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.9740\/mhc.2020.11.326","article-title":"Management of treatment-resistant generalized anxiety disorder","volume":"10","author":"Ansara","year":"2020","journal-title":"Ment Health Clin"},{"issue":"17","key":"10.1016\/j.pharmthera.2023.108574_bb0035","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108574_bb0040","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1530-0277.2006.00215.x","article-title":"Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder","volume":"30","author":"Aoyama","year":"2006","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0045","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.2001.281.3.F454","article-title":"Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1","volume":"281","author":"Arndt","year":"2001","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002130050232","article-title":"Ethanol effects on self-administration of alfentanil, cocaine, and nomifensine in rhesus monkeys","volume":"130","author":"Aspen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/mp.2011.87","article-title":"Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response","volume":"17","author":"Bacq","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"45","key":"10.1016\/j.pharmthera.2023.108574_bb0060","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.1523\/JNEUROSCI.2740-10.2010","article-title":"Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: Organic cation transporter 3, the smoking gun","volume":"30","author":"Baganz","year":"2010","journal-title":"The Journal of Neuroscience"},{"issue":"48","key":"10.1016\/j.pharmthera.2023.108574_bb0065","doi-asserted-by":"crossref","first-page":"18976","DOI":"10.1073\/pnas.0800466105","article-title":"Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice","volume":"105","author":"Baganz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108574_bb0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/pgs-2017-0002","article-title":"OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children","volume":"18","author":"Balyan","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ejn.12050","article-title":"Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus","volume":"37","author":"Barr","year":"2013","journal-title":"The European Journal of Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108574_bb0080","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.3390\/cells11121874","article-title":"Uncovering functional contributions of PMAT (Slc29a4) to monoamine clearance using pharmacobehavioral tools","volume":"11","author":"Beaver","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108574_bb0085","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/ntr\/ntu161","article-title":"Organic cation transporter variation and response to smoking cessation therapies","volume":"16","author":"Bergen","year":"2014","journal-title":"Nicotine & Tobacco Research"},{"issue":"s239","key":"10.1016\/j.pharmthera.2023.108574_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1964.tb04118.x","article-title":"Studies on 5-hydroxytryptamine stores in pineal gland of rat","volume":"63","author":"Bertler","year":"1964","journal-title":"Acta Physiologica Scandinavica. Supplementum"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0095","series-title":"Organic cation transporters in the central nervous system","first-page":"119","article-title":"Substrates and inhibitors of organic cation transporters (OCTs) and plasma membrane monoamine transporter (PMAT) and therapeutic implications","volume":"Vol. 266","author":"B\u00f6nisch","year":"2021"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dky508","article-title":"SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV","volume":"74","author":"Borghetti","year":"2019","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173285","article-title":"Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine","volume":"883","author":"Bowman","year":"2020","journal-title":"European Journal of Pharmacology"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108574_bb0110","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.3390\/ijms21207581","article-title":"Serotonin transporter and plasma membrane monoamine transporter are necessary for the antidepressant-like effects of ketamine in mice","volume":"21","author":"Bowman","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0115","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1124\/dmd.113.055095","article-title":"Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake","volume":"42","author":"Boxberger","year":"2014","journal-title":"Drug Metabolism and Disposition"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108574_bb0120","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1530-0277.2006.00241.x","article-title":"Ethanol-related behaviors in serotonin transporter knockout mice","volume":"30","author":"Boyce-Rustay","year":"2006","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.bjp.0702065","article-title":"Catecholamine transport by the organic cation transporter type 1 (OCT1)","volume":"125","author":"Breidert","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jad.2021.08.124","article-title":"Sex differences in the transcription of monoamine transporters in major depression","volume":"295","author":"Bristow","year":"2021","journal-title":"Journal of Affective Disorders"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108574_bb0135","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1073\/pnas.0401418101","article-title":"Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine","volume":"101","author":"Budygin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108574_bb0140","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1523\/JNEUROSCI.18-13-04854.1998","article-title":"Quantitative evaluation of 5-hydroxytrypatmine (serotonin) neuronal release and uptake: An investigation of extrasynaptic transmission","volume":"18","author":"Bunin","year":"1998","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1476-5381.1965.tb01754.x","article-title":"The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart","volume":"25","author":"Burgen","year":"1965","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Molecular Pharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2023.108574_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-5793(96)01030-7","article-title":"Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1","volume":"395","author":"Busch","year":"1996","journal-title":"FEBS Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pbb.2004.05.020","article-title":"Cocaine, but not alcohol, reinstates cocaine-induced place preferences","volume":"78","author":"Busse","year":"2004","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0278-5846(88)90004-8","article-title":"The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats","volume":"12","author":"Butler","year":"1988","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108574_bb0170","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-09-j0001.2001","article-title":"Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene","volume":"21","author":"Carboni","year":"2001","journal-title":"The Journal of Neuroscience"},{"issue":"5631","key":"10.1016\/j.pharmthera.2023.108574_bb0175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108574_bb0180","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.mp.4001981","article-title":"The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: Evidence from the Spanish PREDICT-gene cohort","volume":"12","author":"Cervilla","year":"2007","journal-title":"Molecular Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108574_bb0185","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s11095-022-03171-8","article-title":"High throughput screening of a prescription drug library for inhibitors of organic cation transporter 3, OCT3","volume":"39","author":"Chen","year":"2022","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jcp.20081","article-title":"Regulation of the human organic cation transporter hOCT1","volume":"201","author":"Ciarimboli","year":"2004","journal-title":"Journal of Cellular Physiology"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108574_bb0195","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.3390\/ijms222413420","article-title":"Role of organic cation transporter 3 and plasma membrane monoamine transporter in the rewarding properties and locomotor sensitizing effects of amphetamine in male and female mice","volume":"22","author":"Clauss","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02064-5","article-title":"Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse","author":"Clauss","year":"2023","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-2236(96)10024-2","article-title":"Transmitter timecourse in the synaptic cleft: Its role in central synaptic function","volume":"19","author":"Clements","year":"1996","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2014.86","article-title":"Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3\u03b2 signaling","volume":"20","author":"Courouss\u00e9","year":"2015","journal-title":"Molecular Psychiatry"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108574_bb0215","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1073\/pnas.0900358106","article-title":"The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway","volume":"106","author":"Cui","year":"2009","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0220","first-page":"P1193","article-title":"Expression and immunolocalization of the plasma membrane monoamine transporter in the brain","volume":"146","author":"Dahlin","year":"2007","journal-title":"Neuroanat"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0225","article-title":"Neurobiology of chronic stress-related psychiatric disorders: Evidence from molecular imaging studies","volume":"1","author":"Davis","year":"2017","journal-title":"Chronic Stress (Thousand Oaks)"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2008.10.004","article-title":"Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy","volume":"121","author":"Daws","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108574_bb0235","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1523\/JNEUROSCI.4050-05.2006","article-title":"Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism","volume":"26","author":"Daws","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41398-019-0674-4","article-title":"Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice","volume":"9","author":"Dieterich","year":"2019","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/jpet.111.187245","article-title":"Synergistic self-administration of ethanol and cocaine directly into the posterior ventral tegmental area: Involvement of serotonin-3 receptors","volume":"340","author":"Ding","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108574_bb0250","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1124\/dmd.115.064824","article-title":"Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors","volume":"43","author":"Duan","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0255","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","article-title":"Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene","volume":"288","author":"Duan","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108475","article-title":"Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones","volume":"186","author":"Duart-Castells","year":"2021","journal-title":"Neuropharmacology"},{"issue":"48","key":"10.1016\/j.pharmthera.2023.108574_bb0265","doi-asserted-by":"crossref","first-page":"P50042","DOI":"10.1074\/jbc.M407913200","article-title":"Identification and characterization of a novel monoamine transporter in the human brain","volume":"279","author":"Engel","year":"2004","journal-title":"JBC"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0270","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0022-3565(25)39392-4","article-title":"Alcohol and cocaine interactions in humans","volume":"266","author":"Farr\u00e9","year":"1993","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajmg.b.30132","article-title":"Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence","volume":"133B","author":"Feinn","year":"2005","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2005.09.016","article-title":"Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus","volume":"1063","author":"Feng","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0285","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.122.545160","article-title":"High-throughput, microplate reader detection of the ASP+ fluorescent substrate to identify novel inhibitors of organic cation transporter-3","author":"Fraser-Spears","year":"2023","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0290","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2018.10.028","article-title":"Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter","volume":"842","author":"Fraser-Spears","year":"2019","journal-title":"European Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108574_bb0295","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/pgs.13.94","article-title":"OCT1 genetic variants influence the pharmacokinetics of morphine in children","volume":"14","author":"Fukuda","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainresrev.2007.02.009","article-title":"From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission","volume":"55","author":"Fuxe","year":"2007","journal-title":"Brain Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.2042-7158.1967.tb08097.x","article-title":"Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection","volume":"19","author":"Fuxe","year":"1967","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2018.11.013","article-title":"Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice","volume":"140","author":"Garbarino","year":"2019","journal-title":"Pharmacological Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108574_bb0315","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.14-10-06084.1994","article-title":"Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain","volume":"14","author":"Garris","year":"1994","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0320","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","article-title":"Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice","volume":"222","author":"Gasser","year":"2017","journal-title":"Brain Structure & Function"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0325","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/ejn.13968","article-title":"Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviors","volume":"48","author":"Gilman","year":"2018","journal-title":"The European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0330","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000115040","article-title":"Caki-1 cells as a model system for the interaction of renally secreted drugs with OCT3","volume":"108","author":"Glube","year":"2008","journal-title":"Nephron. Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108574_bb0335","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA and Cell Biology"},{"issue":"29","key":"10.1016\/j.pharmthera.2023.108574_bb0340","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1523\/JNEUROSCI.1969-13.2013","article-title":"Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking","volume":"33","author":"Graf","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/372549a0","article-title":"Drug excretion mediated by a new prototype of polyspecific transporter","volume":"372","author":"Gr\u00fcndemann","year":"1994","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0350","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/sj.bjp.0704926","article-title":"Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells","volume":"137","author":"Gr\u00fcndemann","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"47","key":"10.1016\/j.pharmthera.2023.108574_bb0355","doi-asserted-by":"crossref","first-page":"P30915","DOI":"10.1074\/jbc.273.47.30915","article-title":"Transport of monoamine transmitters by the organic cation transporter type 2, OCT2","volume":"273","author":"Gr\u00fcndemann","year":"1998","journal-title":"JBC"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.56.1.1","article-title":"Selective substrates for non-neuronal monoamine transporters","volume":"56","author":"Gr\u00fcndemann","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0365","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/1557","article-title":"Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter","volume":"1","author":"Gr\u00fcndemann","year":"1998","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174939","article-title":"Estradiol reduced 5-HT reuptake by downregulating the gene expression of plasma membrane monoamine transporter (PMAT, Slc29a4) through estrogen receptor \u03b2 and the MAPK\/ERK signaling pathway","volume":"924","author":"Gu","year":"2022","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","article-title":"Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics","volume":"381","author":"Haenisch","year":"2010","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0380","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00210-012-0781-8","article-title":"Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2, and hOCT3","volume":"385","author":"Haenisch","year":"2012","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0385","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.114.220350","article-title":"Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers","volume":"352","author":"Han","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108574_bb0390","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.biopsych.2005.11.005","article-title":"Imaging genetics: Perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing","volume":"59","author":"Hariri","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0395","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1087057107299524","article-title":"Pharmacological characterization of a fluorescent uptake assay for the noradrenaline transporter","volume":"12","author":"Hauns\u00f8","year":"2007","journal-title":"Journal of Biomolecular Screening"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0400","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","article-title":"Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3","volume":"136","author":"Hayer-Zillgen","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0405","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/161740","article-title":"Evaluation of genetic variations in organic cation transporter 3 in depressed and nondepressed subjects","author":"Hengen","year":"2011","journal-title":"ISRN Pharmacology"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108574_bb0410","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.3390\/molecules28135270","article-title":"Are there prevalent sex differences in psychostimulant use disorder? A focus on the potential therapeutic efficacy of atypical dopamine uptake inhibitors","volume":"28","author":"Hersey","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchemneu.2013.04.007","article-title":"Organic cation transporter 3 is densely expressed in the intercalated cell groups of the amygdala: Anatomical evidence for a stress hormone-sensitive dopamine clearance system","volume":"52","author":"Hill","year":"2013","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0420","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.physbeh.2010.11.012","article-title":"Natural and synthetic corticosteroid inhibit uptake2-mediated transport in CNS neurons","volume":"104","author":"Hill","year":"2011","journal-title":"Physiology & Behavior"},{"issue":"25","key":"10.1016\/j.pharmthera.2023.108574_bb0425","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1523\/JNEUROSCI.5687-11.2013","article-title":"Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: Uncovering novel targets to treat depression","volume":"33","author":"Horton","year":"2013","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0430","doi-asserted-by":"crossref","first-page":"L829","DOI":"10.1152\/ajplung.00054.2003","article-title":"Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells","volume":"285","author":"Horvath","year":"2003","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0435","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-420118-7.00004-4","article-title":"Monoamine transporter inhibitors and substrates as treatments for stimulant abuse","volume":"69","author":"Howell","year":"2014","journal-title":"Advances in Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108574_bb0440","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/13543776.2016.1180364","article-title":"Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: A patent evaluation","volume":"26","author":"Hu","year":"2016","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.878641","article-title":"Corrigendum: Cell-based radiotracer binding and uptake inhibition assays: A comparison of in vitro methods to assess the potency of drugs that target monoamine transporters","volume":"13","author":"Ilic","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0450","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2005.03299.x","article-title":"Molecular and functional characterization of an Na+\u2212independent choline transporter in rat astrocytes","volume":"94","author":"Inazu","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0455","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1007\/s12035-015-9409-6","article-title":"Role of the 5-HTTLPR and SNP promoter polymorphisms on serotonin transporter gene expression: A closer look at genetic architecture and in vitro functional studies of common and uncommon allelic variants","volume":"53","author":"Iurescia","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0460","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2016.11.002","article-title":"Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement","volume":"170","author":"John","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108574_bb0465","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1128\/MCB.21.16.5471-5477.2001","article-title":"Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene","volume":"21","author":"Jonker","year":"2001","journal-title":"Molecular and Cellular Biology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108574_bb0470","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1128\/MCB.23.21.7902-7908.2003","article-title":"Deficiency in the organic cation transporters 1 and 2 (Oct1\/Oct2 [Slc22a1\/Slc22a2]) in mice abolishes renal secretion of organic cations","volume":"23","author":"Jonker","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00016","article-title":"Glycogen synthase kinase-3 in the etiology and treatment of mood disorders","volume":"4","author":"Jope","year":"2011","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0480","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archgenpsychiatry.2010.189","article-title":"The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation","volume":"68","author":"Karg","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0485","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: A focused review","volume":"69","author":"Karila","year":"2010","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108574_bb0490","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jm2001629","article-title":"Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2","volume":"54","author":"Kido","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108574_bb0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2005.03.014","article-title":"Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice","volume":"382","author":"Kitaichi","year":"2005","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0500","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(03)01321-9","article-title":"Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats","volume":"464","author":"Kitaichi","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"17","key":"10.1016\/j.pharmthera.2023.108574_bb0505","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.3390\/ijms22179658","article-title":"Properties of transport mediated by the human organic cation transporter 2 studied in a polarized three-dimensional epithelial cell culture model","volume":"11","author":"Koepp","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0510","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.118.015578","article-title":"Organic cation transporters in health and disease","volume":"72","author":"Koepsell","year":"2020","journal-title":"Pharmacological Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0515","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002329900475","article-title":"Molecular pharmacology of organic cation transporters in kidney","volume":"167","author":"Koepsell","year":"1999","journal-title":"The Journal of Membrane Biology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108574_bb0520","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0525","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2017.06.011","article-title":"Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22","volume":"137","author":"Krause-Heuer","year":"2017","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0530","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: Structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0535","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1461145707007742","article-title":"Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder","volume":"11","author":"Lazar","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"5292","key":"10.1016\/j.pharmthera.2023.108574_bb0540","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0545","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2013.00014","article-title":"Involvement of organic cation transporter-3 and plasma membrane monoamine transporter in serotonin uptake in human brain vascular smooth muscle cells","volume":"4","author":"Li","year":"2013","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0550","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0006-2952(82)90332-X","article-title":"Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine","volume":"31","author":"Liang","year":"1982","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0555","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1471-4159.1967.tb09548.x","article-title":"Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines","volume":"14","author":"Lichtensteiger","year":"1967","journal-title":"Journal of Neurochemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108574_bb0560","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0006-8993(97)00229-1","article-title":"Effects of ethanol and nomifensine on NE clearance in the cerebellum of young and aged Fischer 344 rats","volume":"756","author":"Lin","year":"1997","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0565","series-title":"Organic cation transporters in the central nervous system","first-page":"199","article-title":"The interaction of organic cation transporters 1-3 and PMAT with psychoactive substances","volume":"Vol. 266","author":"Maier","year":"2021"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108570","article-title":"\u03b1-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters","volume":"190","author":"Maier","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0575","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbb.2015.01.004","article-title":"Modulation of OCT3 expression by stress, and antidepressant-like activity of decynium-22 in an animal model of depression","volume":"131","author":"Marcinkiewcz","year":"2015","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0580","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/PL00005356","article-title":"Comparison between uptake2 and rOCT1: Effects of catecholamines, metanephrines and corticosterone","volume":"359","author":"Martel","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0585","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00171063","article-title":"Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1","volume":"354","author":"Martel","year":"1996","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0590","article-title":"Organic cation transporter 3 (OCT3) is crucial for the reinforcing effects of amphetamine-type stimulants in mice","author":"Mason","year":"2022","journal-title":"Proceedings of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0595","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00424-013-1335-8","article-title":"The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: Transport characteristics and acute regulation of cloned murine OCT3","volume":"466","author":"Massmann","year":"2014","journal-title":"Pfl\u00fcgers Archiv - European Journal of Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0600","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/syn.20301","article-title":"No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics","volume":"60","author":"Mathews","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0605","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuint.2018.09.008","article-title":"\u201cPolytox\u201d synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux","volume":"123","author":"Mayer","year":"2019","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0610","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41386-018-0053-5","article-title":"An unsuspected role for organic cation transporter 3 in the actions of amphetamine","volume":"43","author":"Mayer","year":"2018","journal-title":"Neuropsychopharmacol"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108574_bb0615","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/acer.14445","article-title":"SLC neurotransmitter transporters as therapeutic targets for alcohol use disorder: A narrative review","volume":"44","author":"McColl","year":"2020","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0620","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/npp.2016.187","article-title":"Corticosterone potentiation of cocaine-induced reinstatement of conditioned place preference in mice is mediated by blockade of the organic cation transporter 3","volume":"42","author":"McReynolds","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108574_bb0625","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1681\/ASN.V1171216","article-title":"The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation","volume":"11","author":"Mehrens","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116278","article-title":"Complex components of Shengmai formula interact with organic cation transporter 2 (OCT2) in MDCK cells","volume":"308","author":"Meng","year":"2023","journal-title":"Journal of Ethnopharmacology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108574_bb0635","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1021\/acs.jmedchem.9b01301","article-title":"Opioids as substrates and inhibitors of the genetically highly variable organic cation transporter OCT1","volume":"62","author":"Meyer","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0640","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/1096-9861(20001113)427:2<220::AID-CNE5>3.0.CO;2-P","article-title":"Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals","volume":"427","author":"Miner","year":"2000","journal-title":"The Journal of Comparative Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0645","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cne.10898","article-title":"Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals","volume":"466","author":"Miner","year":"2003","journal-title":"The Journal of Comparative Neurology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0650","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/2211-5463.12183","article-title":"Characterization of murine polyspecific monoamine transporters","volume":"7","author":"Miura","year":"2017","journal-title":"FEBS Open Bio"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108574_bb0655","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.lfs.2004.12.008","article-title":"Intestinal uptake of MPP+ is differently affected by red and white wine","volume":"76","author":"Monteiro","year":"2005","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108574_bb0660","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpsychires.2007.07.009","article-title":"Enhanced norepinephrine output during longterm desipramine treatment: A possible role for the extraneuronal monoamine transporter (SLC22A3)","volume":"42","author":"Mooney","year":"2008","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0665","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(10)91008-8","article-title":"Ethanol action on dopaminergic neurons in the ventral tegmental area: Interaction with intrinsic ion channels and neurotransmitter inputs","volume":"91","author":"Morikawa","year":"2010","journal-title":"Int Rev Neuroobiol"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0670","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2007.09.072","article-title":"The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats","volume":"1184","author":"Nakayama","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0675","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy","volume":"201","author":"Nies","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108574_bb0680","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1523\/JNEUROSCI.17-18-06899.1997","article-title":"The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens","volume":"17","author":"Nirenberg","year":"1997","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0685","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","article-title":"The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons","volume":"16","author":"Nirenberg","year":"1996","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0690","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0005-2736(99)00005-X","article-title":"Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes","volume":"1417","author":"Okuda","year":"1999","journal-title":"Biochimica et Biophysica Acta - Biomembranes"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108574_bb0695","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0004867416637920","article-title":"Associations of 5HTTLPR polymorphism with major depressive disorder and alcohol dependence: A systematic review and meta-analysis","volume":"50","author":"Oo","year":"2016","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0700","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41380-019-0548-4","article-title":"Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression","volume":"25","author":"Orrico-Sanchez","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0705","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41398-023-02596-y","article-title":"Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain","volume":"13","author":"Orrico-Sanchez","year":"2023","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108574_bb0710","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12640-015-9536-x","article-title":"A comprehensive view of the neurotoxicity mechanisms of cocaine and ethanol","volume":"28","author":"Pereira","year":"2015","journal-title":"Neurotoxicity Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2023.108574_bb0715","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1523\/JNEUROSCI.19-17-07356.1999","article-title":"Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens","volume":"19","author":"Pickel","year":"1999","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euroneuro.2011.10.003","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy","volume":"22","author":"Porcelli","year":"2012","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0725","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10571-021-01064-9","article-title":"The roles of serotonin in neuropsychiatric disorders","volume":"42","author":"Pourhamzeh","year":"2022","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0730","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.01.062","article-title":"Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine","volume":"1203","author":"Rahman","year":"2008","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0735","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","volume":"45","author":"Ray","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0740","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2019_251","article-title":"Molecular mechanisms of amphetamines","volume":"258","author":"Reith","year":"2020","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0745","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1471-4159.2000.0751685.x","article-title":"Quantification of ethanol concentrations in the extracellular fluid of the rat brain: In vivo calibration of microdialysis probes","volume":"75","author":"Robinson","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0750","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.physbeh.2019.01.022","article-title":"The role of stress in drug addiction. An integrative review","volume":"202","author":"Ruisoto","year":"2019","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0755","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00165297","article-title":"The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+)","volume":"346","author":"Russ","year":"1992","journal-title":"Schmiedeberg\u2019s Atch Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0760","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/bph.12520","article-title":"A quantitative model of amphetamine action on the 5-HT transporter","volume":"171","author":"Sandtner","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0765","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/appi.ajp.161.5.909","article-title":"Toward a rapidly acting antidepressant: The normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis","volume":"161","author":"Schildkraut","year":"2004","journal-title":"The American Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108574_bb0770","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00424-013-1395-9","article-title":"Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules","volume":"466","author":"Schlatter","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0775","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jnr.10521","article-title":"Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice","volume":"71","author":"Schmitt","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0780","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF00176331","article-title":"Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells)","volume":"341","author":"Sch\u00f6mig","year":"1990","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0785","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3","article-title":"Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter","volume":"420","author":"Schroeter","year":"2000","journal-title":"The Journal of Comparative Neurology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108574_bb0790","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.1074\/jbc.M209824200","article-title":"Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate","volume":"278","author":"Schwartz","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0795","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbr.2014.07.030","article-title":"An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings","volume":"273","author":"Sharpley","year":"2014","journal-title":"Behavioural Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0800","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3565(25)28709-2","article-title":"Kinetics of serotonin accumulation into slices from rat brain: Relationship to catecholamine uptake","volume":"175","author":"Shaskan","year":"1970","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0805","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jchemneu.2016.09.006","article-title":"Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse","volume":"83\u201384","author":"Shirasaka","year":"2017","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0810","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10253890.2020.1781084","article-title":"Priorities in stress research: A view from the U.S. National Institute of Mental Health","volume":"24","author":"Simmons","year":"2021","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0815","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4137\/JEN.S40231","article-title":"Amphetamine withdrawal differentially increases the expression of organic cation transporter 3 and serotonin transporter in limbic brain regions","volume":"10","author":"Solanki","year":"2016","journal-title":"Journal of Experimental Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.11.005","article-title":"Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine","volume":"49","author":"Sun","year":"2014","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0825","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0306-4522(96)00030-9","article-title":"Immunocytochemical detection of the serotonin transporter in rat brain","volume":"73","author":"Sur","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0830","series-title":"Organic cation transporters in the central nervous system","first-page":"41","article-title":"Organic cation transporter expression and function in the CNS","volume":"Vol. 266","author":"Sweet","year":"2021"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0835","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FPC.0000000000000269","article-title":"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans","volume":"27","author":"Taghavi","year":"2017","journal-title":"Pharmacogenetics and Genomics"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0840","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.alcohol.2014.07.006","article-title":"Ethanol and cocaine: Environmental place conditioning, stereotypy, and synergism in planarians","volume":"48","author":"Tallarida","year":"2014","journal-title":"Alcohol"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0845","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00414-020-02325-w","article-title":"Comparison of ethanol concentrations in the human brain determined by magnetic resonance spectroscopy and serum ethanol concentrations","volume":"134","author":"Thierauf-Emberger","year":"2020","journal-title":"International Journal of Legal Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0850","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0855","series-title":"World drug report 2022","author":"United Nations Office on Drugs and Crime","year":"2022"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0860","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-3565(24)37859-0","article-title":"Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs","volume":"287","author":"Urakami","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0865","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05506.x","article-title":"Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice","volume":"106","author":"Vialou","year":"2008","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0870","first-page":"P616","article-title":"Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain","volume":"144","author":"Vialou","year":"2007","journal-title":"Neuroanat"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0875","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: Challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0880","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiological Reviews"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108574_bb0885","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.118.082131","article-title":"Disposition of methamphetamine and major metabolites in mice: Role of organic cation transporter 3 in tissue-selective accumulation of Para-hydroxymethamphetamine","volume":"46","author":"Wagner","year":"2018","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0890","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pnpbp.2014.03.005","article-title":"Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action","volume":"53","author":"Wang","year":"2014","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0895","article-title":"Organic cation transporters are involved in fluoxetine transport across the blood-brain barrier in vivo and in vitro","volume":"19","author":"Wang","year":"2022","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0900","article-title":"Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters","author":"Weber","year":"2022","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0905","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1192\/bjp.bp.105.009522","article-title":"Life events, first depression onset and the serotonin transporter gene","volume":"188","author":"Wilhelm","year":"2006","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0910","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiology of Stress"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0915","series-title":"Global status report on alcohol and health 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0920","series-title":"World mental health report: Transforming mental health for all","year":"2022"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0925","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/jnc.13363","article-title":"Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins","volume":"135","author":"Wu","year":"2015","journal-title":"Journal of Neurochemistry"},{"issue":"49","key":"10.1016\/j.pharmthera.2023.108574_bb0930","doi-asserted-by":"crossref","first-page":"P32776","DOI":"10.1074\/jbc.273.49.32776","article-title":"Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain","volume":"273","author":"Wu","year":"1998","journal-title":"JBC"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0935","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00702-009-0205-1","article-title":"Decreased anxiety in mice lacking the organic cation transporter 3","volume":"116","author":"Wultsch","year":"2009","journal-title":"Journal of Neural Transmission"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108574_bb0940","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.metabol.2005.01.007","article-title":"Genes, stress, and depression","volume":"54","author":"Wurtman","year":"2005","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0945","doi-asserted-by":"crossref","first-page":"F682","DOI":"10.1152\/ajprenal.00302.2006","article-title":"Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells","volume":"292","author":"Xia","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108574_bb0950","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/glia.22484","article-title":"Molecular mechanism of histamine clearance by primary human astrocytes","volume":"61","author":"Yoshikawa","year":"2013","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108574_bb0955","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-3565(25)24730-9","article-title":"Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport","volume":"257","author":"Zaczek","year":"1991","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0960","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-3565(24)37595-0","article-title":"Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa)","volume":"286","author":"Zhang","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0965","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-8993(98)00691-X","article-title":"Serotonin transporters are located on the axons beyond the synaptic junctions: Anatomical and functional evidence","volume":"805","author":"Zhou","year":"1998","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108574_bb0970","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-4159.2010.06738.x","article-title":"Interaction of organic cation transporter 3 (SLC22A3) and amphetamine","volume":"114","author":"Zhu","year":"2010","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108574_bb0975","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.phrs.2012.01.008","article-title":"Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action","volume":"65","author":"Zhu","year":"2012","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108574_bb0980","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jff.2019.01.048","article-title":"Luteolin shows antidepressant-like effect by inhibiting and downregulating plasma membrane monoamine transporter (PMAT, Slc29a4)","volume":"54","author":"Zhu","year":"2019","journal-title":"Journal of Functional Foods"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108574_bb0985","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/MCB.21.13.4188-4196.2001","article-title":"Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3\/Slc22a3-deficient mice","volume":"21","author":"Zwart","year":"2001","journal-title":"Molecular and Cellular Biology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:39:43Z","timestamp":1759012783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":197,"alternative-id":["S0163725823002383"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108574","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic cation transporters in psychiatric and substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108574"}}